Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Molecular & Cellular Proteomics : MCP
|
October 30, 2012
Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers
Alaina P Boyer, Timothy S Collier, Ilan Vidavsky, et al.
Plos One
|
July 5, 2013
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data
Runjun D Kumar, Li-Wei Chang, Matthew J Ellis, et al.
BMC Nephrology
|
November 10, 2024
Sacituzumab-govitecan-induced severe acute tubulointerstitial nephritis requiring hemodialysis
Geneva Guarin, Audrey Netzel, Karen Marie Flores, et al.
Current Opinion in Structural Biology
|
November 7, 2006
Protein tyrosine kinase-substrate interactions
Ron Bose, Marc A Holbert, Kerry A Pickin, et al.
The Journal of Biological Chemistry
|
July 12, 2013
Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface
Timothy S Collier, Karthikeyan Diraviyam, John Monsey, et al.
Nature
|
November 30, 2007
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Xuewu Zhang, Kerry A Pickin, Ron Bose, et al.
The Journal of Biological Chemistry
|
November 23, 2016
Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases
Theodore R Keppel, Kwabena Sarpong, Elisa M Murray, et al.
Bioinformatics (Oxford, England)
|
July 26, 2015
Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data
Runjun D Kumar, Adam C Searleman, S Joshua Swamidass, et al.
Molecular & Cellular Proteomics : MCP
|
March 23, 2011
Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase
Hao Zhang, Wei Shen, Don Rempel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 12, 2015
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor
Noa Efrat Ben-Baruch, Ron Bose, Shyam M Kavuri, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Molecular & Cellular Proteomics : MCP
|
October 30, 2012
Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers
Alaina P Boyer, Timothy S Collier, Ilan Vidavsky, et al.
Plos One
|
July 5, 2013
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data
Runjun D Kumar, Li-Wei Chang, Matthew J Ellis, et al.
BMC Nephrology
|
November 10, 2024
Sacituzumab-govitecan-induced severe acute tubulointerstitial nephritis requiring hemodialysis
Geneva Guarin, Audrey Netzel, Karen Marie Flores, et al.
Current Opinion in Structural Biology
|
November 7, 2006
Protein tyrosine kinase-substrate interactions
Ron Bose, Marc A Holbert, Kerry A Pickin, et al.
The Journal of Biological Chemistry
|
July 12, 2013
Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface
Timothy S Collier, Karthikeyan Diraviyam, John Monsey, et al.
Nature
|
November 30, 2007
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Xuewu Zhang, Kerry A Pickin, Ron Bose, et al.
The Journal of Biological Chemistry
|
November 23, 2016
Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases
Theodore R Keppel, Kwabena Sarpong, Elisa M Murray, et al.
Bioinformatics (Oxford, England)
|
July 26, 2015
Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data
Runjun D Kumar, Adam C Searleman, S Joshua Swamidass, et al.
Molecular & Cellular Proteomics : MCP
|
March 23, 2011
Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase
Hao Zhang, Wei Shen, Don Rempel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 12, 2015
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor
Noa Efrat Ben-Baruch, Ron Bose, Shyam M Kavuri, et al.
Page
of 8